Otonomy experimentation: Ho everybody, anyone of... - Tinnitus UK

Tinnitus UK

10,074 members5,230 posts

Otonomy experimentation

Antinni1971 profile image
9 Replies

Ho everybody, anyone of you Heard about a medication called oto313 (glacyclidine) to heal Tinnitus?

Written by
Antinni1971 profile image
Antinni1971
To view profiles and participate in discussions please or .
9 Replies
Happyrosie profile image
Happyrosie

There is NO magic pill for tinnitus. Anyone who tries to sell you a pill is looking to make lots of money, Go to the British Tinnitus Association website and look for their pages on what does and does not help.

TinnitusUKPat profile image
TinnitusUKPatPartner in reply to Happyrosie

I'd say, if it is successful, it's more of a Magic Injection into the middle ear...🤔

doglover1973 profile image
doglover1973 in reply to TinnitusUKPat

That sounds painful 😬

mrsheathbar profile image
mrsheathbar

this is a clinical trial currently going on now for unilateral tinnitus. clinicaltrials.gov/ct2/show...

Antinni1971 profile image
Antinni1971 in reply to mrsheathbar

clinicaltrials.gov/ct2/resu... And what about this?

Frog7749 profile image
Frog7749

It will be interesting to find out more about this clinical trail, may be they are working on a drug that help with tinnitus.

Antinni1971 profile image
Antinni1971 in reply to Frog7749

It seems good, but I don't speak a good English, mabye Someone of you could interpretate Better than me!!!

investors.otonomy.com/news-...

Frog7749 profile image
Frog7749

I am not the best to ask, English is my first language but I am dyslexic

TinnitusUKPat profile image
TinnitusUKPatPartner

OTO-313 is an intratympanic drug, and the progress from stage 2 to a stage 3 trial in the US is positive. This is significant as it involves many more people than the earlier stages and is often where the effectiveness of pharmaceutical products is demonstrated or found to be unclear, due to the larger pool of participants whose variables can support the effectiveness of a therapy or indicate that it is best suited to a sub-set of users.

The unilateral tinnitus caveat is something to be mindful about - like a lot of approaches to treating or managing tinnitus, it may work for a specific group. People with tinnitus present bilaterally are not currently in the scope of this trial. If good outcomes are identified for test participants with single-sided tinnitus, that's a step in a very positive direction.

Not what you're looking for?